Prenetics Global Ltd. has completed the sale of its 35% equity interest in Insighta to Tencent for total cash consideration of $70 million. The transaction significantly increases Prenetics’ cash resources, boosts total adjusted liquidity to $171.1 million, and leaves the company with zero debt. The deal is part of Prenetics’ strategy to streamline operations and focus on expanding its IM8 health brand globally.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Prenetics Global Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202602170800PRIMZONEFULLFEED9655746) on February 17, 2026, and is solely responsible for the information contained therein.